Vai al contenuto principale della pagina
| Autore: |
Dorst Johannes
|
| Titolo: |
Apheresis in Neurological Disorders
|
| Pubblicazione: | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica: | 1 online resource (174 p.) |
| Soggetto topico: | Medicine and Nursing |
| Soggetto non controllato: | acute relapsing multiple sclerosis |
| Alzheimer's clinical syndrome | |
| antibody | |
| apheresis | |
| autoantibodies | |
| autoimmune encephalitis | |
| chronic inflammatory demyelinating polyneuropathy | |
| class IV | |
| CRP | |
| dementia | |
| Guillain-Barré syndrome | |
| immunoadsorption | |
| inflammation | |
| Inflammatory neuropathy | |
| limbic encephalitis | |
| multiple sclerosis | |
| Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | |
| n/a | |
| neurological diseases | |
| NMDAR (N-Methyl-D-Aspartat) | |
| optic neuritis | |
| paraneoplastic | |
| paranodal antibodies | |
| plasma exchange | |
| plasmapheresis | |
| relapse | |
| ß2 adrenoreceptor autoantibody | |
| steroids | |
| stroke | |
| therapeutic apheresis | |
| therapeutic plasma exchange | |
| α1-Adrenergic receptor | |
| Persona (resp. second.): | DorstJohannes |
| Sommario/riassunto: | Apheresis refers to an extracorporeal therapy which aims at removing pathological constituents from the patients' blood. Due to the development of new techniques as well as the discovery of novel autoimmune antibodies, it is increasingly recognized as an important therapeutic option for a variety of autoimmune-mediated neurological disorders, including multiple sclerosis, myasthenia gravis, autoimmune encephalitis, Guillain-Barré syndrome, and many others. Therapeutic plasma exchange (TPE) constitutes the standard method of apheresis for most indications, while immunoadsorption (IA) offers a more specific, low-risk alternative. Both methods aim at removing auto-antibodies from the blood. Evidence for most neurological diseases is still low. Interestingly, more recent developments suggest that apheresis is not limited to the removal of autoantibodies but may also be useful in neurodegenerative and possibly even in acute vascular disorders. |
| Titolo autorizzato: | Apheresis in Neurological Disorders ![]() |
| Formato: | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910557107403321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |